

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.69086381 |
| 2 | L-amino acid import (GO:0043092) | 3.44876577 |
| 3 | positive regulation of fibroblast migration (GO:0010763) | 3.41944882 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21737475 |
| 5 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.20227381 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.10015392 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.94447258 |
| 8 | * growth hormone receptor signaling pathway (GO:0060396) | 2.88744647 |
| 9 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.87646768 |
| 10 | sodium ion export (GO:0071436) | 2.87286773 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 2.87079729 |
| 12 | negative thymic T cell selection (GO:0045060) | 2.83032251 |
| 13 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.82216183 |
| 14 | negative T cell selection (GO:0043383) | 2.81867781 |
| 15 | cell migration involved in heart development (GO:0060973) | 2.67497554 |
| 16 | amino acid import (GO:0043090) | 2.67328589 |
| 17 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.67295997 |
| 18 | positive regulation of Rap GTPase activity (GO:0032854) | 2.67028103 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 2.65387344 |
| 20 | nucleobase catabolic process (GO:0046113) | 2.64154390 |
| 21 | positive T cell selection (GO:0043368) | 2.63645023 |
| 22 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.62383338 |
| 23 | cellular response to epinephrine stimulus (GO:0071872) | 2.59999454 |
| 24 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.58577377 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 2.57910810 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.51328791 |
| 27 | nerve growth factor signaling pathway (GO:0038180) | 2.50590988 |
| 28 | cardiac ventricle formation (GO:0003211) | 2.50590930 |
| 29 | regulation of Rap GTPase activity (GO:0032317) | 2.48610857 |
| 30 | activated T cell proliferation (GO:0050798) | 2.47931938 |
| 31 | cerebellar granule cell differentiation (GO:0021707) | 2.45372018 |
| 32 | cellular response to ethanol (GO:0071361) | 2.43582827 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.42058371 |
| 34 | * cellular response to growth hormone stimulus (GO:0071378) | 2.41321669 |
| 35 | interkinetic nuclear migration (GO:0022027) | 2.40808382 |
| 36 | regulation of sequestering of triglyceride (GO:0010889) | 2.40621076 |
| 37 | response to muramyl dipeptide (GO:0032495) | 2.40489267 |
| 38 | positive thymic T cell selection (GO:0045059) | 2.40488723 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.39689549 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.39208982 |
| 41 | potassium ion import (GO:0010107) | 2.38928942 |
| 42 | positive regulation of extracellular matrix organization (GO:1903055) | 2.38502647 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 2.38059537 |
| 44 | positive regulation of histone deacetylation (GO:0031065) | 2.33436526 |
| 45 | cardiac chamber formation (GO:0003207) | 2.32032755 |
| 46 | thymic T cell selection (GO:0045061) | 2.29902948 |
| 47 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.29726649 |
| 48 | T cell selection (GO:0045058) | 2.29628681 |
| 49 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.28643124 |
| 50 | cell communication by electrical coupling (GO:0010644) | 2.27586854 |
| 51 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.27520622 |
| 52 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.27454011 |
| 53 | establishment of protein localization to Golgi (GO:0072600) | 2.23810719 |
| 54 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.22632338 |
| 55 | fatty acid transmembrane transport (GO:1902001) | 2.22210164 |
| 56 | positive regulation of fatty acid oxidation (GO:0046321) | 2.21609070 |
| 57 | sleep (GO:0030431) | 2.21327482 |
| 58 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.21298810 |
| 59 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.21176673 |
| 60 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.19919679 |
| 61 | synaptic vesicle maturation (GO:0016188) | 2.18951461 |
| 62 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.18516394 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.17615484 |
| 64 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.16822269 |
| 65 | relaxation of cardiac muscle (GO:0055119) | 2.16584354 |
| 66 | carnitine shuttle (GO:0006853) | 2.16069681 |
| 67 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.15944997 |
| 68 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.15389541 |
| 69 | valine metabolic process (GO:0006573) | 2.14556035 |
| 70 | response to epinephrine (GO:0071871) | 2.14394206 |
| 71 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.14285558 |
| 72 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.14219170 |
| 73 | protein targeting to Golgi (GO:0000042) | 2.14064519 |
| 74 | negative regulation of T cell mediated immunity (GO:0002710) | 2.13935600 |
| 75 | locomotory exploration behavior (GO:0035641) | 2.13000726 |
| 76 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.11771795 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 2.10743506 |
| 78 | response to nerve growth factor (GO:1990089) | 2.08949061 |
| 79 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.08949061 |
| 80 | regulation of beta-amyloid formation (GO:1902003) | 2.08116869 |
| 81 | germinal center formation (GO:0002467) | 2.07954279 |
| 82 | regulation of ARF protein signal transduction (GO:0032012) | 2.07571649 |
| 83 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.07375419 |
| 84 | cellular sodium ion homeostasis (GO:0006883) | 2.05882218 |
| 85 | cellular response to monoamine stimulus (GO:0071868) | 2.03754647 |
| 86 | cellular response to catecholamine stimulus (GO:0071870) | 2.03754647 |
| 87 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.03353481 |
| 88 | clathrin coat assembly (GO:0048268) | 2.03177655 |
| 89 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.02730341 |
| 90 | dendrite morphogenesis (GO:0048813) | 2.01549006 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 2.00885079 |
| 92 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.00835244 |
| 93 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.00322145 |
| 94 | * insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.00219798 |
| 95 | nucleus localization (GO:0051647) | 1.99320861 |
| 96 | neurotransmitter secretion (GO:0007269) | 1.98960739 |
| 97 | layer formation in cerebral cortex (GO:0021819) | 1.98592649 |
| 98 | exploration behavior (GO:0035640) | 1.98419379 |
| 99 | negative regulation of cell killing (GO:0031342) | 1.98152421 |
| 100 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.98152421 |
| 101 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.97700485 |
| 102 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 1.97256418 |
| 103 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 1.96463486 |
| 104 | activation of protein kinase A activity (GO:0034199) | 1.96208501 |
| 105 | regulation of triglyceride catabolic process (GO:0010896) | 1.95629381 |
| 106 | postsynaptic membrane organization (GO:0001941) | 1.95012285 |
| 107 | heart field specification (GO:0003128) | 1.94701656 |
| 108 | secondary heart field specification (GO:0003139) | 1.94701656 |
| 109 | regulation of female receptivity (GO:0045924) | 1.94204999 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 1.93837876 |
| 111 | positive regulation of p38MAPK cascade (GO:1900745) | 1.93796332 |
| 112 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 1.93741709 |
| 113 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.93718270 |
| 114 | T cell migration (GO:0072678) | 1.92983770 |
| 115 | negative regulation of type 2 immune response (GO:0002829) | 1.91448115 |
| 116 | cell communication involved in cardiac conduction (GO:0086065) | 1.91229735 |
| 117 | low-density lipoprotein particle clearance (GO:0034383) | 1.91165880 |
| 118 | potassium ion homeostasis (GO:0055075) | 1.91134637 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 1.90865189 |
| 120 | histone lysine demethylation (GO:0070076) | 1.90778524 |
| 121 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.90403095 |
| 122 | triglyceride catabolic process (GO:0019433) | 1.89440061 |
| 123 | regulation of histone deacetylation (GO:0031063) | 1.88367517 |
| 124 | neutral lipid catabolic process (GO:0046461) | 1.85613021 |
| 125 | acylglycerol catabolic process (GO:0046464) | 1.85613021 |
| 126 | intracellular lipid transport (GO:0032365) | 1.85586843 |
| 127 | positive regulation of glycogen metabolic process (GO:0070875) | 1.85448256 |
| 128 | presynaptic membrane assembly (GO:0097105) | 1.85285053 |
| 129 | phospholipid homeostasis (GO:0055091) | 1.83753771 |
| 130 | positive regulation of natural killer cell differentiation (GO:0032825) | 1.83499178 |
| 131 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.83086249 |
| 132 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 1.82421039 |
| 133 | proline transport (GO:0015824) | 1.82279261 |
| 134 | regulation of glycogen (starch) synthase activity (GO:2000465) | 1.82225285 |
| 135 | histone H3-K36 demethylation (GO:0070544) | 1.81206843 |
| 136 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.79574920 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.79574920 |
| 138 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 1.78699497 |
| 139 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.78547427 |
| 140 | negative regulation of protein autophosphorylation (GO:0031953) | 1.77288885 |
| 141 | regulation of gamma-delta T cell differentiation (GO:0045586) | 1.76905703 |
| 142 | negative regulation of lipid storage (GO:0010888) | 1.76205907 |
| 143 | membrane assembly (GO:0071709) | 1.76135696 |
| 144 | response to interleukin-15 (GO:0070672) | 1.75322894 |
| 145 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.73046557 |
| 146 | positive regulation of muscle hypertrophy (GO:0014742) | 1.73046557 |
| 147 | Golgi to endosome transport (GO:0006895) | 1.72689236 |
| 148 | cellular response to prostaglandin stimulus (GO:0071379) | 1.72401601 |
| 149 | regulation of fatty acid oxidation (GO:0046320) | 1.72140085 |
| 150 | regulation of p38MAPK cascade (GO:1900744) | 1.71543226 |
| 151 | negative regulation of fatty acid transport (GO:2000192) | 1.71496650 |
| 152 | establishment of nucleus localization (GO:0040023) | 1.71259928 |
| 153 | regulation of cholesterol storage (GO:0010885) | 1.69410702 |
| 154 | regulation of lipid catabolic process (GO:0050994) | 1.68615126 |
| 155 | regulation of ARF GTPase activity (GO:0032312) | 1.67986090 |
| 156 | cellular response to cholesterol (GO:0071397) | 1.67256129 |
| 157 | regulation of glutamate receptor signaling pathway (GO:1900449) | 1.67088046 |
| 158 | phospholipid translocation (GO:0045332) | 1.66320563 |
| 159 | lipid translocation (GO:0034204) | 1.66320563 |
| 160 | * positive regulation of glucose import (GO:0046326) | 1.65747149 |
| 161 | dendritic spine morphogenesis (GO:0060997) | 1.65558033 |
| 162 | macroautophagy (GO:0016236) | 1.65519425 |
| 163 | positive regulation of macrophage cytokine production (GO:0060907) | 1.65244198 |
| 164 | antigen processing and presentation of endogenous antigen (GO:0019883) | 1.65225080 |
| 165 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.64021237 |
| 166 | regulation of gamma-delta T cell activation (GO:0046643) | 1.63994784 |
| 167 | vocalization behavior (GO:0071625) | 1.63897086 |
| 168 | serine transport (GO:0032329) | 1.63742631 |
| 169 | brown fat cell differentiation (GO:0050873) | 1.63616847 |
| 170 | glutamate secretion (GO:0014047) | 1.63082316 |
| 171 | regulation of synapse structural plasticity (GO:0051823) | 1.62429620 |
| 172 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 1.62189882 |
| 173 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.62185207 |
| 174 | glycine transport (GO:0015816) | 1.61380654 |
| 175 | alanine transport (GO:0032328) | 1.61361791 |
| 176 | positive regulation of cholesterol efflux (GO:0010875) | 1.61047727 |
| 177 | lipid storage (GO:0019915) | 1.60836241 |
| 178 | cellular extravasation (GO:0045123) | 1.60592419 |
| 179 | cortical actin cytoskeleton organization (GO:0030866) | 1.60336417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.33726834 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23193469 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98282044 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92091339 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90809925 |
| 6 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82177998 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78884675 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.72916422 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71611698 |
| 10 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63713313 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61675317 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57894412 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55138118 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52087772 |
| 15 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51886496 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.51325216 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50042946 |
| 18 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44492990 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44215399 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44215399 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43357241 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41826150 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40267704 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40147901 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39408671 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.38307036 |
| 27 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.35380307 |
| 28 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34691193 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34083445 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33414218 |
| 31 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32452869 |
| 32 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32090079 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32060502 |
| 34 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31760552 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31657818 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29646244 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.29277156 |
| 38 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28078181 |
| 39 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.28064756 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27786597 |
| 41 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26446771 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23831083 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23797973 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22333681 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22333681 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21803243 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20928801 |
| 48 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20065972 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19548048 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19154470 |
| 51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17845091 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17268331 |
| 53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.15644212 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15407729 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14551857 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14323944 |
| 57 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13821132 |
| 58 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13663745 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13431363 |
| 60 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12191447 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11326713 |
| 62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11286680 |
| 63 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11045959 |
| 64 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10847497 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09549101 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09018239 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07506579 |
| 68 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07355234 |
| 69 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07277992 |
| 70 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07172939 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06732129 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06428442 |
| 73 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06051104 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05745374 |
| 75 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.04582240 |
| 76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03988459 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03975950 |
| 78 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03685435 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02863167 |
| 80 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02834635 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02723146 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02409734 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02390032 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02363110 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02282712 |
| 86 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02089718 |
| 87 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01514887 |
| 88 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01100104 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00564151 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99553741 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99398902 |
| 92 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99242527 |
| 93 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98293410 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97902285 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97596663 |
| 96 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97373460 |
| 97 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97182124 |
| 98 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96470296 |
| 99 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96267477 |
| 100 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96114886 |
| 101 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.95579117 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94699538 |
| 103 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.93490155 |
| 104 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.93252222 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92989017 |
| 106 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.92495786 |
| 107 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91931880 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91278591 |
| 109 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91161636 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91157516 |
| 111 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90995574 |
| 112 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90389350 |
| 113 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.90359068 |
| 114 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89724348 |
| 115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89670508 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89030739 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89030739 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88920244 |
| 119 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88396386 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88377539 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88052714 |
| 122 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87588806 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87419157 |
| 124 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85136054 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84780463 |
| 126 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84507158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 3.23641545 |
| 2 | * MP0004130_abnormal_muscle_cell | 2.76755600 |
| 3 | MP0000569_abnormal_digit_pigmentation | 2.76282801 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.70161664 |
| 5 | MP0003880_abnormal_central_pattern | 2.31738592 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.30628065 |
| 7 | MP0003045_fibrosis | 2.21016582 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.16044926 |
| 9 | MP0004185_abnormal_adipocyte_glucose | 2.09742322 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.03510197 |
| 11 | MP0003329_amyloid_beta_deposits | 2.02033195 |
| 12 | MP0001851_eye_inflammation | 2.00670618 |
| 13 | MP0002064_seizures | 1.96533691 |
| 14 | MP0000465_gastrointestinal_hemorrhage | 1.83370717 |
| 15 | MP0005670_abnormal_white_adipose | 1.79085332 |
| 16 | MP0002166_altered_tumor_susceptibility | 1.77534721 |
| 17 | MP0005409_darkened_coat_color | 1.77235678 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 1.76337769 |
| 19 | MP0002254_reproductive_system_inflammat | 1.73914322 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.73571539 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.73403041 |
| 22 | * MP0005666_abnormal_adipose_tissue | 1.68754138 |
| 23 | MP0009745_abnormal_behavioral_response | 1.65573712 |
| 24 | MP0003690_abnormal_glial_cell | 1.65106867 |
| 25 | MP0001486_abnormal_startle_reflex | 1.62458956 |
| 26 | MP0002009_preneoplasia | 1.60003616 |
| 27 | MP0003303_peritoneal_inflammation | 1.59553532 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.56803654 |
| 29 | MP0005365_abnormal_bile_salt | 1.51514519 |
| 30 | MP0001881_abnormal_mammary_gland | 1.50630195 |
| 31 | MP0003879_abnormal_hair_cell | 1.49109578 |
| 32 | MP0003252_abnormal_bile_duct | 1.39606117 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.39196186 |
| 34 | MP0004510_myositis | 1.37474578 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.36422228 |
| 36 | * MP0005375_adipose_tissue_phenotype | 1.33844082 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.30910200 |
| 38 | MP0002006_tumorigenesis | 1.30703906 |
| 39 | MP0002272_abnormal_nervous_system | 1.29842865 |
| 40 | MP0004270_analgesia | 1.28103092 |
| 41 | * MP0001800_abnormal_humoral_immune | 1.27698585 |
| 42 | MP0000920_abnormal_myelination | 1.26961184 |
| 43 | * MP0002118_abnormal_lipid_homeostasis | 1.25627679 |
| 44 | MP0001958_emphysema | 1.24930990 |
| 45 | MP0003868_abnormal_feces_composition | 1.24564318 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.23268857 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.22448205 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.22160731 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.20834208 |
| 50 | MP0004883_abnormal_blood_vessel | 1.20045064 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.17234395 |
| 52 | MP0003631_nervous_system_phenotype | 1.16803963 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.15607873 |
| 54 | MP0006082_CNS_inflammation | 1.15317582 |
| 55 | MP0005275_abnormal_skin_tensile | 1.14733836 |
| 56 | * MP0005334_abnormal_fat_pad | 1.13566862 |
| 57 | MP0001873_stomach_inflammation | 1.13443716 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.12023998 |
| 59 | MP0004381_abnormal_hair_follicle | 1.11956572 |
| 60 | MP0002971_abnormal_brown_adipose | 1.11787928 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.10355275 |
| 62 | MP0008569_lethality_at_weaning | 1.09810326 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.09268355 |
| 64 | MP0003091_abnormal_cell_migration | 1.07787245 |
| 65 | MP0005535_abnormal_body_temperature | 1.07054151 |
| 66 | MP0005166_decreased_susceptibility_to | 1.06826877 |
| 67 | MP0005671_abnormal_response_to | 1.06236334 |
| 68 | MP0003633_abnormal_nervous_system | 1.06103897 |
| 69 | MP0005187_abnormal_penis_morphology | 1.05814120 |
| 70 | MP0003279_aneurysm | 1.05417159 |
| 71 | MP0003635_abnormal_synaptic_transmissio | 1.05384487 |
| 72 | MP0003866_abnormal_defecation | 1.05359594 |
| 73 | MP0003075_altered_response_to | 1.03876585 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.02826689 |
| 75 | MP0000579_abnormal_nail_morphology | 1.02179282 |
| 76 | MP0009384_cardiac_valve_regurgitation | 1.01340948 |
| 77 | MP0004858_abnormal_nervous_system | 1.00723705 |
| 78 | MP0002133_abnormal_respiratory_system | 1.00216446 |
| 79 | MP0005388_respiratory_system_phenotype | 1.00216446 |
| 80 | MP0002723_abnormal_immune_serum | 0.99856166 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 0.99809786 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.99699820 |
| 83 | MP0009046_muscle_twitch | 0.99182133 |
| 84 | MP0002734_abnormal_mechanical_nocicepti | 0.97216520 |
| 85 | MP0003632_abnormal_nervous_system | 0.96894397 |
| 86 | MP0002896_abnormal_bone_mineralization | 0.96195467 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.95391017 |
| 88 | * MP0005025_abnormal_response_to | 0.95212714 |
| 89 | * MP0002420_abnormal_adaptive_immunity | 0.95020215 |
| 90 | MP0003787_abnormal_imprinting | 0.94809161 |
| 91 | MP0003634_abnormal_glial_cell | 0.94541166 |
| 92 | MP0000751_myopathy | 0.94474921 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.94181559 |
| 94 | MP0006138_congestive_heart_failure | 0.93602664 |
| 95 | MP0002933_joint_inflammation | 0.93014351 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.92522225 |
| 97 | MP0004885_abnormal_endolymph | 0.92138282 |
| 98 | * MP0001819_abnormal_immune_cell | 0.92117182 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.91891773 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.90231985 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.89800471 |
| 102 | MP0004924_abnormal_behavior | 0.89800471 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.89482727 |
| 104 | MP0003724_increased_susceptibility_to | 0.89473294 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.88423772 |
| 106 | MP0002168_other_aberrant_phenotype | 0.88384492 |
| 107 | MP0001790_abnormal_immune_system | 0.88073560 |
| 108 | MP0005387_immune_system_phenotype | 0.88073560 |
| 109 | MP0000249_abnormal_blood_vessel | 0.86056606 |
| 110 | MP0009278_abnormal_bone_marrow | 0.85977315 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.85556570 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.84798946 |
| 113 | MP0000609_abnormal_liver_physiology | 0.84715078 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.84380548 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.84065922 |
| 116 | MP0002972_abnormal_cardiac_muscle | 0.82590223 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.81823185 |
| 118 | * MP0002452_abnormal_antigen_presenting | 0.80880948 |
| 119 | MP0004484_altered_response_of | 0.80693508 |
| 120 | MP0002419_abnormal_innate_immunity | 0.78717857 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.77950813 |
| 122 | MP0004147_increased_porphyrin_level | 0.77463933 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.77451850 |
| 124 | MP0002063_abnormal_learning/memory/cond | 0.76484578 |
| 125 | MP0008004_abnormal_stomach_pH | 0.76429309 |
| 126 | MP0005360_urolithiasis | 0.75807543 |
| 127 | MP0000685_abnormal_immune_system | 0.75759861 |
| 128 | MP0001666_abnormal_nutrient_absorption | 0.72152818 |
| 129 | * MP0009115_abnormal_fat_cell | 0.71626176 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.71020031 |
| 131 | MP0003828_pulmonary_edema | 0.70660258 |
| 132 | MP0003436_decreased_susceptibility_to | 0.70551690 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.69390620 |
| 134 | MP0005448_abnormal_energy_balance | 0.69315931 |
| 135 | MP0001177_atelectasis | 0.68252019 |
| 136 | MP0010368_abnormal_lymphatic_system | 0.67849560 |
| 137 | * MP0002078_abnormal_glucose_homeostasis | 0.67029247 |
| 138 | MP0000604_amyloidosis | 0.66677508 |
| 139 | MP0005000_abnormal_immune_tolerance | 0.66570688 |
| 140 | MP0002060_abnormal_skin_morphology | 0.66528708 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.66446924 |
| 142 | MP0008874_decreased_physiological_sensi | 0.66383967 |
| 143 | MP0005620_abnormal_muscle_contractility | 0.65474986 |
| 144 | MP0004947_skin_inflammation | 0.65178126 |
| 145 | MP0005385_cardiovascular_system_phenoty | 0.64824024 |
| 146 | MP0001544_abnormal_cardiovascular_syste | 0.64824024 |
| 147 | MP0003172_abnormal_lysosome_physiology | 0.64632048 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64454470 |
| 149 | MP0004272_abnormal_basement_membrane | 0.64028015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 3.98326598 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 3.93620591 |
| 3 | Neonatal hypoglycemia (HP:0001998) | 3.85212322 |
| 4 | Diplopia (HP:0000651) | 3.27343052 |
| 5 | Abnormality of binocular vision (HP:0011514) | 3.27343052 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.22171463 |
| 7 | Febrile seizures (HP:0002373) | 3.06124802 |
| 8 | Focal motor seizures (HP:0011153) | 2.92320236 |
| 9 | Macroorchidism (HP:0000053) | 2.87342514 |
| 10 | Eczematoid dermatitis (HP:0000976) | 2.77150823 |
| 11 | Eosinophilia (HP:0001880) | 2.73758705 |
| 12 | Broad metatarsal (HP:0001783) | 2.72291704 |
| 13 | Atonic seizures (HP:0010819) | 2.62731175 |
| 14 | Hematochezia (HP:0002573) | 2.54904459 |
| 15 | Aortic aneurysm (HP:0004942) | 2.51593201 |
| 16 | Focal seizures (HP:0007359) | 2.50322847 |
| 17 | Increased IgM level (HP:0003496) | 2.47878732 |
| 18 | Action tremor (HP:0002345) | 2.42791083 |
| 19 | Postural instability (HP:0002172) | 2.42539746 |
| 20 | Spontaneous hematomas (HP:0007420) | 2.40975621 |
| 21 | Buphthalmos (HP:0000557) | 2.40299716 |
| 22 | Granulocytopenia (HP:0001913) | 2.36141573 |
| 23 | Lip pit (HP:0100267) | 2.33347813 |
| 24 | Truncal ataxia (HP:0002078) | 2.29744070 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 2.28986316 |
| 26 | Abnormality of eosinophils (HP:0001879) | 2.28062213 |
| 27 | Myokymia (HP:0002411) | 2.27774485 |
| 28 | Abnormality of the columella (HP:0009929) | 2.23687384 |
| 29 | Ankle clonus (HP:0011448) | 2.22142961 |
| 30 | Complement deficiency (HP:0004431) | 2.21062591 |
| 31 | Sudden death (HP:0001699) | 2.19278874 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18730815 |
| 33 | Narrow palate (HP:0000189) | 2.15340331 |
| 34 | Hypochromic anemia (HP:0001931) | 2.13188871 |
| 35 | Slow saccadic eye movements (HP:0000514) | 2.11241184 |
| 36 | Enlarged penis (HP:0000040) | 2.09923411 |
| 37 | T lymphocytopenia (HP:0005403) | 2.08701233 |
| 38 | Bundle branch block (HP:0011710) | 2.08673018 |
| 39 | Scanning speech (HP:0002168) | 2.05397989 |
| 40 | Shallow orbits (HP:0000586) | 2.02006487 |
| 41 | Myocardial infarction (HP:0001658) | 2.01963720 |
| 42 | Overgrowth (HP:0001548) | 2.00654735 |
| 43 | Muscle fiber splitting (HP:0003555) | 1.99554266 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 1.98627168 |
| 45 | Hypoplastic ischia (HP:0003175) | 1.97398298 |
| 46 | Sparse lateral eyebrow (HP:0005338) | 1.97038041 |
| 47 | Striae distensae (HP:0001065) | 1.96589212 |
| 48 | Leukocytosis (HP:0001974) | 1.95671538 |
| 49 | Abnormal eating behavior (HP:0100738) | 1.92935270 |
| 50 | Insidious onset (HP:0003587) | 1.92934288 |
| 51 | Termporal pattern (HP:0011008) | 1.92934288 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92211847 |
| 53 | Subaortic stenosis (HP:0001682) | 1.92211847 |
| 54 | Exostoses (HP:0100777) | 1.91962191 |
| 55 | Lymphangioma (HP:0100764) | 1.91628812 |
| 56 | Abnormality of the ischium (HP:0003174) | 1.91530888 |
| 57 | Abnormality of complement system (HP:0005339) | 1.90357301 |
| 58 | Gingivitis (HP:0000230) | 1.88726509 |
| 59 | Absent frontal sinuses (HP:0002688) | 1.88451188 |
| 60 | Aortic dissection (HP:0002647) | 1.87925061 |
| 61 | Deep venous thrombosis (HP:0002625) | 1.87197724 |
| 62 | Intention tremor (HP:0002080) | 1.86322327 |
| 63 | Mitral valve prolapse (HP:0001634) | 1.86180646 |
| 64 | Vasculitis (HP:0002633) | 1.84218322 |
| 65 | Spastic gait (HP:0002064) | 1.83916202 |
| 66 | Excessive salivation (HP:0003781) | 1.83256116 |
| 67 | Drooling (HP:0002307) | 1.83256116 |
| 68 | Mutism (HP:0002300) | 1.83021425 |
| 69 | Subcapsular cataract (HP:0000523) | 1.82781659 |
| 70 | Epidermoid cyst (HP:0200040) | 1.81834539 |
| 71 | Abnormal social behavior (HP:0012433) | 1.80826551 |
| 72 | Impaired social interactions (HP:0000735) | 1.80826551 |
| 73 | Arterial thrombosis (HP:0004420) | 1.80741589 |
| 74 | Inappropriate behavior (HP:0000719) | 1.80315487 |
| 75 | Abnormality of the fingertips (HP:0001211) | 1.79517189 |
| 76 | Oligomenorrhea (HP:0000876) | 1.79461839 |
| 77 | Myositis (HP:0100614) | 1.78112426 |
| 78 | Lower limb muscle weakness (HP:0007340) | 1.77829552 |
| 79 | Hemorrhage of the eye (HP:0011885) | 1.77783501 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 1.76095787 |
| 81 | Optic neuritis (HP:0100653) | 1.76095787 |
| 82 | Annular pancreas (HP:0001734) | 1.75560178 |
| 83 | Hyporeflexia of lower limbs (HP:0002600) | 1.73649432 |
| 84 | Mask-like facies (HP:0000298) | 1.73298206 |
| 85 | Accelerated skeletal maturation (HP:0005616) | 1.72890511 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 1.72499510 |
| 87 | Poor eye contact (HP:0000817) | 1.72086415 |
| 88 | Cerebral aneurysm (HP:0004944) | 1.71699521 |
| 89 | Papilledema (HP:0001085) | 1.71485990 |
| 90 | Arterial tortuosity (HP:0005116) | 1.71118883 |
| 91 | Abnormality of the nasal septum (HP:0000419) | 1.70409092 |
| 92 | Supranuclear gaze palsy (HP:0000605) | 1.70178286 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.69160344 |
| 94 | EMG: neuropathic changes (HP:0003445) | 1.68740838 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 1.67914078 |
| 96 | Turricephaly (HP:0000262) | 1.67779704 |
| 97 | Gingival bleeding (HP:0000225) | 1.67632075 |
| 98 | Fatigue (HP:0012378) | 1.67006219 |
| 99 | Syncope (HP:0001279) | 1.66622395 |
| 100 | Genetic anticipation (HP:0003743) | 1.66125479 |
| 101 | Vascular tortuosity (HP:0004948) | 1.65679999 |
| 102 | Colitis (HP:0002583) | 1.65387512 |
| 103 | Dysdiadochokinesis (HP:0002075) | 1.65218568 |
| 104 | Aneurysm (HP:0002617) | 1.64998221 |
| 105 | Germ cell neoplasia (HP:0100728) | 1.64569372 |
| 106 | Orchitis (HP:0100796) | 1.63776600 |
| 107 | Depressed nasal tip (HP:0000437) | 1.63600126 |
| 108 | Vertigo (HP:0002321) | 1.63434131 |
| 109 | Asymmetric septal hypertrophy (HP:0001670) | 1.63296551 |
| 110 | Disinhibition (HP:0000734) | 1.62553082 |
| 111 | Pulmonary embolism (HP:0002204) | 1.62174063 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.61846403 |
| 113 | Peripheral hypomyelination (HP:0007182) | 1.61260178 |
| 114 | Atrioventricular block (HP:0001678) | 1.60948991 |
| 115 | Prolonged bleeding time (HP:0003010) | 1.60174429 |
| 116 | Bone cyst (HP:0012062) | 1.58983189 |
| 117 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.58924698 |
| 118 | Abnormality of the corticospinal tract (HP:0002492) | 1.58684095 |
| 119 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.58590063 |
| 120 | Mitral stenosis (HP:0001718) | 1.58577100 |
| 121 | Abnormality of T cells (HP:0002843) | 1.58010925 |
| 122 | Absence seizures (HP:0002121) | 1.57961940 |
| 123 | Dysmetria (HP:0001310) | 1.57275139 |
| 124 | Neoplasm of the heart (HP:0100544) | 1.56684080 |
| 125 | Milia (HP:0001056) | 1.56649190 |
| 126 | Obstructive sleep apnea (HP:0002870) | 1.56606803 |
| 127 | Stereotypic behavior (HP:0000733) | 1.56375127 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.55269574 |
| 129 | Open mouth (HP:0000194) | 1.55067680 |
| 130 | Asymmetry of the thorax (HP:0001555) | 1.54760513 |
| 131 | Neurofibrillary tangles (HP:0002185) | 1.54760141 |
| 132 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.54460280 |
| 133 | Aqueductal stenosis (HP:0002410) | 1.53961539 |
| 134 | Nephritis (HP:0000123) | 1.53727013 |
| 135 | Periodontitis (HP:0000704) | 1.53674104 |
| 136 | Right ventricular cardiomyopathy (HP:0011663) | 1.53440937 |
| 137 | Difficulty running (HP:0009046) | 1.52777134 |
| 138 | Hyperlipoproteinemia (HP:0010980) | 1.52585499 |
| 139 | Epistaxis (HP:0000421) | 1.52413497 |
| 140 | Abnormality of the 4th metacarpal (HP:0010012) | 1.52357103 |
| 141 | Abnormality of saccadic eye movements (HP:0000570) | 1.52174270 |
| 142 | Blue irides (HP:0000635) | 1.51881005 |
| 143 | Amyloidosis (HP:0011034) | 1.51857879 |
| 144 | Increased cerebral lipofuscin (HP:0011813) | 1.51703265 |
| 145 | Dysmetric saccades (HP:0000641) | 1.51698283 |
| 146 | Hemangiomatosis (HP:0007461) | 1.51577387 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.51471552 |
| 148 | Keratoconjunctivitis sicca (HP:0001097) | 1.50840380 |
| 149 | Visceral angiomatosis (HP:0100761) | 1.50782625 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.49479687 |
| 151 | Lower limb asymmetry (HP:0100559) | 1.49301156 |
| 152 | Atrophic scars (HP:0001075) | 1.47578524 |
| 153 | Hemiplegia (HP:0002301) | 1.46919756 |
| 154 | Exotropia (HP:0000577) | 1.46618475 |
| 155 | Acanthosis nigricans (HP:0000956) | 1.45571623 |
| 156 | Infantile muscular hypotonia (HP:0008947) | 1.45182486 |
| 157 | Vitreoretinal degeneration (HP:0000655) | 1.44091699 |
| 158 | Broad-based gait (HP:0002136) | 1.43113835 |
| 159 | Hyperventilation (HP:0002883) | 1.42492247 |
| 160 | Abnormality of the common coagulation pathway (HP:0010990) | 1.42077483 |
| 161 | Onion bulb formation (HP:0003383) | 1.41543715 |
| 162 | Ketoacidosis (HP:0001993) | 1.40533479 |
| 163 | Cerebral inclusion bodies (HP:0100314) | 1.40117012 |
| 164 | Torticollis (HP:0000473) | 1.39916399 |
| 165 | Scapular winging (HP:0003691) | 1.39483240 |
| 166 | Epileptic encephalopathy (HP:0200134) | 1.39123932 |
| 167 | Stomach cancer (HP:0012126) | 1.38510219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 3.29125430 |
| 2 | PRPF4B | 2.77888685 |
| 3 | CAMK1D | 2.66980028 |
| 4 | CAMK1G | 2.48475985 |
| 5 | MARK1 | 2.31778008 |
| 6 | FRK | 2.13621935 |
| 7 | TRIB3 | 1.95229615 |
| 8 | FGFR2 | 1.87235146 |
| 9 | FES | 1.86426784 |
| 10 | FGFR3 | 1.76829158 |
| 11 | LATS1 | 1.73087362 |
| 12 | TAOK3 | 1.70554440 |
| 13 | JAK1 | 1.70205718 |
| 14 | RIPK1 | 1.67843566 |
| 15 | BMPR2 | 1.62055499 |
| 16 | TGFBR2 | 1.47061574 |
| 17 | LMTK2 | 1.46896944 |
| 18 | EPHB1 | 1.45420043 |
| 19 | EPHA3 | 1.43052094 |
| 20 | INSRR | 1.42101620 |
| 21 | DAPK2 | 1.36690904 |
| 22 | KIT | 1.33920630 |
| 23 | DMPK | 1.32982978 |
| 24 | PIK3CG | 1.30263300 |
| 25 | AKT3 | 1.27950864 |
| 26 | PHKG1 | 1.27306825 |
| 27 | PHKG2 | 1.27306825 |
| 28 | UHMK1 | 1.22488089 |
| 29 | MAP3K13 | 1.22095060 |
| 30 | SGK3 | 1.20043235 |
| 31 | MAP3K14 | 1.19257487 |
| 32 | ZAP70 | 1.18592789 |
| 33 | CDK12 | 1.18252481 |
| 34 | FGFR4 | 1.17610692 |
| 35 | MAP3K2 | 1.17398363 |
| 36 | JAK3 | 1.16755705 |
| 37 | TXK | 1.15594618 |
| 38 | SIK2 | 1.13805937 |
| 39 | TNK2 | 1.12553093 |
| 40 | MAP4K1 | 1.12249200 |
| 41 | PKN2 | 1.09176091 |
| 42 | TLK1 | 1.07814140 |
| 43 | SYK | 1.03463064 |
| 44 | NEK6 | 1.02969387 |
| 45 | PRKCH | 1.02128140 |
| 46 | PKN1 | 1.02010585 |
| 47 | MAPK12 | 1.01631799 |
| 48 | RIPK4 | 1.01350651 |
| 49 | CSF1R | 0.99223599 |
| 50 | SGK2 | 0.98771667 |
| 51 | BTK | 0.98037585 |
| 52 | TYRO3 | 0.97497843 |
| 53 | MARK2 | 0.97427816 |
| 54 | * RET | 0.95904464 |
| 55 | JAK2 | 0.94411768 |
| 56 | MAP2K3 | 0.93545217 |
| 57 | PRKAA2 | 0.89825799 |
| 58 | FLT3 | 0.88984948 |
| 59 | IKBKE | 0.88233699 |
| 60 | MAP3K7 | 0.87911040 |
| 61 | PDGFRA | 0.87582697 |
| 62 | MAP3K9 | 0.86152355 |
| 63 | NLK | 0.85396191 |
| 64 | BLK | 0.85204294 |
| 65 | GRK6 | 0.84136766 |
| 66 | SGK494 | 0.82992194 |
| 67 | SGK223 | 0.82992194 |
| 68 | TTN | 0.82005594 |
| 69 | CAMKK1 | 0.81830334 |
| 70 | CDK19 | 0.81545170 |
| 71 | TYK2 | 0.81133842 |
| 72 | NTRK1 | 0.77435356 |
| 73 | CASK | 0.77294072 |
| 74 | PTK6 | 0.76169282 |
| 75 | CSK | 0.74853360 |
| 76 | TNIK | 0.74152039 |
| 77 | STK38 | 0.73616137 |
| 78 | TEC | 0.73399709 |
| 79 | MAP3K4 | 0.72446174 |
| 80 | CHUK | 0.71939935 |
| 81 | PDK1 | 0.70971953 |
| 82 | MAP3K1 | 0.70245834 |
| 83 | PDPK1 | 0.65868541 |
| 84 | * LCK | 0.64906881 |
| 85 | NUAK1 | 0.64386742 |
| 86 | MAP3K6 | 0.64123692 |
| 87 | CDC42BPA | 0.64012641 |
| 88 | HIPK2 | 0.63847206 |
| 89 | MAPK7 | 0.63646846 |
| 90 | TAOK1 | 0.63234107 |
| 91 | MINK1 | 0.62828087 |
| 92 | STK11 | 0.62062048 |
| 93 | * PDGFRB | 0.61377735 |
| 94 | NTRK2 | 0.59831103 |
| 95 | MAP2K4 | 0.59327341 |
| 96 | MAPK4 | 0.59187278 |
| 97 | TBK1 | 0.58632806 |
| 98 | PAK6 | 0.58176424 |
| 99 | OBSCN | 0.58152072 |
| 100 | PRKD3 | 0.57745710 |
| 101 | MOS | 0.57658880 |
| 102 | DYRK1A | 0.57491911 |
| 103 | PRKAA1 | 0.56837984 |
| 104 | CAMKK2 | 0.56169374 |
| 105 | MAPK10 | 0.55956587 |
| 106 | CDK5 | 0.55744914 |
| 107 | SGK1 | 0.55034895 |
| 108 | WNK1 | 0.54210242 |
| 109 | PAK3 | 0.54205090 |
| 110 | CAMK1 | 0.54125010 |
| 111 | GRK5 | 0.53510912 |
| 112 | MAPK13 | 0.52655106 |
| 113 | ERBB2 | 0.52527611 |
| 114 | GRK7 | 0.51396871 |
| 115 | ERN1 | 0.51192667 |
| 116 | CAMK4 | 0.51115202 |
| 117 | GSK3A | 0.50994790 |
| 118 | ITK | 0.50536331 |
| 119 | EPHA4 | 0.50514914 |
| 120 | MAP3K10 | 0.50246290 |
| 121 | PRKCE | 0.49583520 |
| 122 | IRAK2 | 0.49414554 |
| 123 | EEF2K | 0.48744834 |
| 124 | DDR2 | 0.48575379 |
| 125 | TRPM7 | 0.48567502 |
| 126 | BMX | 0.48527566 |
| 127 | NTRK3 | 0.48097934 |
| 128 | * PRKD1 | 0.47191719 |
| 129 | * FYN | 0.47189936 |
| 130 | KSR2 | 0.47008016 |
| 131 | HCK | 0.44302209 |
| 132 | IRAK1 | 0.43853043 |
| 133 | PRKCQ | 0.43328294 |
| 134 | PRKCZ | 0.42989231 |
| 135 | CDK9 | 0.42408727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58497684 |
| 2 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.93071925 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.71206581 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53445038 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.37034096 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32064208 |
| 7 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28524857 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24053344 |
| 9 | Renin secretion_Homo sapiens_hsa04924 | 1.20746354 |
| 10 | * Insulin resistance_Homo sapiens_hsa04931 | 1.10265079 |
| 11 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10137520 |
| 12 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06670129 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04699891 |
| 14 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03001897 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01360752 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.00461952 |
| 17 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97338618 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 0.97245053 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96749391 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 0.95742846 |
| 21 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95469158 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94347201 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93930078 |
| 24 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93578335 |
| 25 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93459108 |
| 26 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92503731 |
| 27 | * Platelet activation_Homo sapiens_hsa04611 | 0.92399773 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91625942 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91189402 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89372366 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 0.89357478 |
| 32 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89166731 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87574864 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87491671 |
| 35 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87398331 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86847138 |
| 37 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86383326 |
| 38 | * Cholinergic synapse_Homo sapiens_hsa04725 | 0.86318830 |
| 39 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.85694134 |
| 40 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83650585 |
| 41 | * Focal adhesion_Homo sapiens_hsa04510 | 0.82998692 |
| 42 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82917500 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82003093 |
| 44 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.81811403 |
| 45 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81784948 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 0.81249361 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81151697 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80977148 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.80598653 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80479910 |
| 51 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79509903 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78193396 |
| 53 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77650574 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77547986 |
| 55 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77220632 |
| 56 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76788494 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 0.76587002 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76213337 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75771859 |
| 60 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75598065 |
| 61 | * Glioma_Homo sapiens_hsa05214 | 0.75510806 |
| 62 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75007359 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74653868 |
| 64 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74603494 |
| 65 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73946593 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73883005 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73075641 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72769560 |
| 69 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72752402 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72719668 |
| 71 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71746214 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.71473833 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71461361 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71399173 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.71174826 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.71091345 |
| 77 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.70962746 |
| 78 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70181152 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69603694 |
| 80 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.69204702 |
| 81 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68649768 |
| 82 | * Amoebiasis_Homo sapiens_hsa05146 | 0.68557435 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68528908 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68490722 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67307638 |
| 86 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67253479 |
| 87 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66729701 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66284976 |
| 89 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65326442 |
| 90 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65302251 |
| 91 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65298585 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65196353 |
| 93 | * Measles_Homo sapiens_hsa05162 | 0.64821797 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64814647 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.64392264 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.64360789 |
| 97 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64064422 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.63830734 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63637528 |
| 100 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63399582 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.63226808 |
| 102 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61531566 |
| 103 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61500678 |
| 104 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60332074 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59391989 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59314377 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58912830 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58878684 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58299175 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58180022 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57403981 |
| 112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57307735 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.56850924 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56559754 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56489355 |
| 116 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56197285 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56186517 |
| 118 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56185041 |
| 119 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56178714 |
| 120 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56106095 |
| 121 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.55265297 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55207686 |
| 123 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55163062 |
| 124 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54973359 |
| 125 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53381768 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53308389 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.52671509 |
| 128 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52496713 |

